Prothena Corporation PLC reports results for the quarter ended in December - Earnings Summary

Prothena

15/02/2024 22:52

* Prothena Corporation PLC  PRTA.OQ  reported a quarterly
adjusted
loss of $1.26​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of 12 cents.  The mean expectation of nine analysts for the
quarter was for a loss of $1.22 per share. Wall Street expected
results to range from $-1.46 to -87 cents per share.
    * Revenue fell 99.4% to $316.00 thousand from a year ago;
analysts
expected $2.15 million. 
    * Prothena Corporation PLC's reported EPS for the quarter
was a
loss of $1.26​.
    * The company reported a quarterly loss of $67.48 million.
    * Prothena Corporation PLC shares had fallen by 24.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Prothena
Corporation PLC is $80.50 
This summary was machine generated from LSEG data February 15 at
10:52 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.22          -1.26          Missed
 Sep. 30 2023      -0.32          0.38           Beat
 Jun. 30 2023      -1.00          -1.03          Missed
 Mar. 31 2023      -0.94          -0.89          Beat